Literature DB >> 24990592

LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Jie Zheng1, Shuna Yu, Yanchun Qiao, Hongxia Zhang, Shujuan Liang, Hailiang Wang, Yuqing Liu, Fenghua Zhou, Jiying Jiang, Shijun Lu.   

Abstract

PURPOSE: The LIM and SH3 protein 1 (LASP-1) is a focal adhesion protein, and its expression has been reported to be increased in many malignant tumors. However, the role of LASP-1 in gastric cancer is still unknown. The aim of this study was to determine the relationship of LASP-1 expression with the progression and prognosis of gastric cancer.
METHODS: Expression of LASP-1 was evaluated in gastric cancer tissues and cell lines by immunohistochemistry and Western blot analysis. The relationship between LASP-1 expression and clinicopathological characteristics was analyzed. Using RNA interference, the effects of LASP-1 on cell proliferation, migration and invasion were investigated in gastric cancer cell lines both in vitro and in vivo.
RESULTS: The LASP-1 was overexpressed in gastric cancer tissues and cell lines. LASP-1 expression was significantly associated with tumor size, invasive depth, TNM stage, lymph node metastasis and p53 expression (all P < 0.05). Multivariate survival analysis showed that LASP-1 expression was recognized as an independent prognostic factor of patient's survival. Knockdown of LASP-1 inhibited cell proliferation, migration and invasion in vitro as well as tumorigenesis and metastasis in vivo.
CONCLUSIONS: Our study showed that LASP-1, overexpressed in gastric cancer and associated with poor prognosis, plays an important role in the growth and metastasis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990592     DOI: 10.1007/s00432-014-1759-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

Review 1.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

2.  Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.

Authors:  Thomas G P Grunewald; Ulrike Kammerer; Elfriede Schulze; Detlef Schindler; Arnd Honig; Michael Zimmer; Elke Butt
Journal:  Exp Cell Res       Date:  2006-01-23       Impact factor: 3.905

3.  Lasp-1 binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo.

Authors:  Catherine S Chew; Xunsheng Chen; John A Parente; Shannan Tarrer; Curtis Okamoto; Hai-Yen Qin
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

4.  Short-term retention of actin filament binding proteins on lamellipodial actin bundles.

Authors:  Hiroyuki Nakagawa; Asako G Terasaki; Hiroshi Suzuki; Kazuyo Ohashi; Shigeaki Miyamoto
Journal:  FEBS Lett       Date:  2006-05-04       Impact factor: 4.124

5.  Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.

Authors:  Takeshi Chiyomaru; Hideki Enokida; Kazumori Kawakami; Shuichi Tatarano; Yousuke Uchida; Kazuya Kawahara; Kenryu Nishiyama; Naohiko Seki; Masayuki Nakagawa
Journal:  Urol Oncol       Date:  2010-09-16       Impact factor: 3.498

6.  Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.

Authors:  Liang Zhao; Hui Wang; Chao Liu; Yawei Liu; Xiaoyan Wang; Shuang Wang; Xuegang Sun; Jianming Li; Yongjian Deng; Yong Jiang; Yanqing Ding
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

7.  Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell.

Authors:  C S Chew; J A Parente; C Zhou; E Baranco; X Chen
Journal:  Am J Physiol       Date:  1998-07

8.  Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.

Authors:  T G P Grunewald; U Kammerer; C Winkler; D Schindler; A Sickmann; A Honig; E Butt
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

9.  Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice.

Authors:  Shuna Yu; Jie Zheng; Zhengchen Jiang; Caixing Shi; Jin Li; Xiaodong Du; Hailiang Wang; Jiying Jiang; Xin Wang
Journal:  Int J Mol Sci       Date:  2013-08-29       Impact factor: 5.923

10.  L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Authors:  Dong-liang Chen; Zhao-lei Zeng; Jing Yang; Chao Ren; De-shen Wang; Wen-jing Wu; Rui-hua Xu
Journal:  J Hematol Oncol       Date:  2013-06-27       Impact factor: 17.388

View more
  17 in total

1.  Clinicopathological features of gastric adenocarcinoma patients with metachronous distant metastasis.

Authors:  Junjie Bao; Guofan Qu; Wangshu Fu; Yanjing Li; Haibin Song; Yuzhe Wei; Yingwei Xue
Journal:  Tumour Biol       Date:  2015-04-29

2.  Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.

Authors:  Hongchen Zhang; Zhizhen Li; Bingfeng Chu; Fei Zhang; Yijian Zhang; Fayong Ke; Yuanyuan Chen; Yi Xu; Shibo Liu; Shuai Zhao; Haibin Liang; Mingzhe Weng; Xiangsong Wu; Maolan Li; Wenguang Wu; Zhiwei Quan; Yingbin Liu; Yong Zhang; Wei Gong
Journal:  Tumour Biol       Date:  2016-01-04

3.  MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.

Authors:  Xuexia Pan; Zhimin Wang; Bin Wan; Zhenwen Zheng
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

4.  LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.

Authors:  Cas Vanderheijden; Thomas Vaessen; Youssef Yakkioui; Robert Riedl; Yasin Temel; Koos Hovinga; Govert Hoogland
Journal:  J Neurooncol       Date:  2022-05-04       Impact factor: 4.506

5.  LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.

Authors:  Anjana Vaman V S; Heiko Poppe; Roland Houben; Thomas G P Grunewald; Matthias Goebeler; Elke Butt
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 6.  An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Authors:  Martin F Orth; Alex Cazes; Elke Butt; Thomas G P Grunewald
Journal:  Oncotarget       Date:  2015-01-01

7.  Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.

Authors:  Johannes F Fahrmann; Dmitry Grapov; Brett S Phinney; Carol Stroble; Brian C DeFelice; William Rom; David R Gandara; Yanhong Zhang; Oliver Fiehn; Harvey Pass; Suzanne Miyamoto
Journal:  Clin Proteomics       Date:  2016-10-27       Impact factor: 3.988

8.  MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1.

Authors:  Zhaolan Hu; Yanhui Cui; Yanhui Zhou; Kaiying Zhou; Xiaoqing Qiao; Changqi Li; Shuang Wang
Journal:  Onco Targets Ther       Date:  2016-11-14       Impact factor: 4.147

9.  Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1.

Authors:  Hui Li; Guoqing Liu; Ke Pan; Xiongying Miao; Yong Xie
Journal:  Oncotarget       Date:  2017-09-30

10.  Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma.

Authors:  Fan-Yun Kong; Ting Zhu; Nan Li; Yun-Fei Cai; Kai Zhou; Xiao Wei; Yan-Bo Kou; Hong-Juan You; Kui-Yang Zheng; Ren-Xian Tang
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.